← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Cabergoline currently has availability issues reported in 4 European registers: Germany, Spain, Ireland, Italy.
Shortage ATC N04BC06 · also listed as: Cabergolin · CABERGOLINA · Cabergoline · data refreshed 13 September 2026
As of 13 September 2026, 4 of the 9 tracked registers list current availability issues for Cabergoline, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2026-02-02 and has now been open for about 7 months. Where agencies state a cause, manufacturing problems lead with 3 of the 4 stated-cause reports, followed by active-ingredient (API) supply issues with 1. The furthest expected-resolution date currently on file is 2026-10-19; the earliest is 2026-10-16. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Italy reported first (2026-02-02), with Spain following roughly 6 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Ireland, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Cabergoline is coded N04BC06 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Cabaseril 1 mg + 1 more productsCabaseril 2 mg | 2026-06-01 | 2026-10-16 | Probleme beim Wirkstoffhersteller Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage CABERGOLINA TEVA 1 mg COMPRIMIDOS EFG , 20 comprimidos | 2026-08-23 | 2026-10-19 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇪 Ireland | Shortage Dostinex 500 microgram tablets | 2026-06-01 | 2026-06-30 | API shortage/unavailability (Global) Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇮🇹 Italy | Shortage DOSTINEX | 2026-02-02 | — | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Cabergoline in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | CABERGOLINA TEVA 1 mg COMPRIMIDOS EFG , 20 comprimidos | Shortage | 2026-08-23 | 2026-10-19 | Existen otros medicamentos con el mismo principio activo y m |
| 🇩🇪 DE | Cabaseril 1 mg | Shortage | 2026-06-01 | 2026-10-16 | Probleme beim Wirkstoffhersteller |
| 🇩🇪 DE | Cabaseril 2 mg | Shortage | 2026-06-01 | 2026-10-16 | Probleme beim Wirkstoffhersteller |
| 🇮🇪 IE | Dostinex 500 microgram tablets | Shortage | 2026-06-01 | 2026-06-30 | API shortage/unavailability (Global) |
| 🇮🇹 IT | DOSTINEX | Shortage | 2026-02-02 | — | Problemi produttivi |
Yes. As of 13 September 2026, availability issues are reported in: Germany, Spain, Ireland, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-16 to 2026-10-19. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Cabergoline: BfArM (Germany), AEMPS CIMA (Spain), HPRA (Ireland), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Cabergoline — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cabergoline/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Cabergoline availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cabergoline/">Cabergoline shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>